You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
HT-production of Abs using Interaction Trap in Yeast
SBC: AFFOMIX, INC. Topic: N/ADESCRIPTION (provided by applicant): Affomix would like to commercialize antibody chips to enable researchers to study the human proteome. Currently, researchers use gene chips as a surrogate means to estimate the concentration of the vast variety of pro teins in cells and tissues. But given the choice, most researchers would prefer to study the proteins directly because of the; i) poor correla ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Huperzine for Cognitive and Functional Impairment in Schizophrenia
SBC: BIOMEDISYN CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Schizophrenia affects approximately 3 million people in the US, and it is one of the leading causes of disability. Currently available drugs are only partially effective, particularly for the cognitive impairments that contribute to functional loss. A new investigational drug, BMD-101, has been shown to have neuroprotective, neurotrophic, cholinergic, and dopa ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
The Development of Cross-Platform Quantitative Standards for Diagnostic Immunohis
SBC: HISTORX, INC. Topic: N/ADESCRIPTION (provided by applicant): Patient-specific therapies targeted to the phenotype of individual tumors represent the future of cancer treatment. The prototypes for this type of therapy are Herceptin and Tamoxifen, which are only given to patients e xpressing a particular level of HER2 and estrogen receptor (ER), respectively. It is likely that dozens of such therapies will be developed for ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Tick Midgut Thrombin Inhibitor as a Vaccine Target
SBC: L2 DIAGNOSTICS LLC Topic: N/ADESCRIPTION (provided by applicant): We seek in this proposal to develop a tick vaccine to block tick feeding and pathogen transmission to the vertebrate host. Ticks can harbor bacterial, viral and protozoan pathogens and infected ticks transmit pathogens to the mammalian host during feeding, causing human and cattle disease worldwide. Ixodid ticks are obligate hematophagous arthropods that feed ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
New Serodiagnostics for Isocyanate Exposure, A Major Cause of Occupational Asthma
SBC: L2 DIAGNOSTICS LLC Topic: N/ADESCRIPTION (provided by applicant): Occupational exposures are estimated to account for 9-15% of adult asthma cases. Among the most common causes of occupational asthma are isocyanates, reactive chemicals necessary to make polyurethane products (construct ion, automotive, military, medical, foam, coatings, adhesives). Millions of people are currently employed in industries that utilize isocyanate ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Experimental Pharmacology and Chemical Studies of Nikkomycin Z
SBC: VALLEY FEVER THERAPIES LLC Topic: N/ADESCRIPTION (provided by applicant): Coccidioidomycosis is a regional fungal disease in desert areas of the Southwestern U.S. and is of particular importance to Arizona and California. The importance of this disease extends beyond the endemic areas due to extensive travel to these locations. Infection with Coccidioides spp. may cause illness ranging from a mild, self-limiting, pulmonary syndrome ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
